161 related articles for article (PubMed ID: 26049667)
1. LRG1 modulates invasion and migration of glioma cell lines through TGF-β signaling pathway.
Zhong D; He G; Zhao S; Li J; Lang Y; Ye W; Li Y; Jiang C; Li X
Acta Histochem; 2015 Jul; 117(6):551-8. PubMed ID: 26049667
[TBL] [Abstract][Full Text] [Related]
2. TGF-β1 promotes motility and invasiveness of glioma cells through activation of ADAM17.
Lu Y; Jiang F; Zheng X; Katakowski M; Buller B; To SS; Chopp M
Oncol Rep; 2011 May; 25(5):1329-35. PubMed ID: 21359495
[TBL] [Abstract][Full Text] [Related]
3. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
[TBL] [Abstract][Full Text] [Related]
4. Ionizing radiation promotes migration and invasion of cancer cells through transforming growth factor-beta-mediated epithelial-mesenchymal transition.
Zhou YC; Liu JY; Li J; Zhang J; Xu YQ; Zhang HW; Qiu LB; Ding GR; Su XM; Mei-Shi ; Guo GZ
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1530-7. PubMed ID: 22115555
[TBL] [Abstract][Full Text] [Related]
5. EWI-2 negatively regulates TGF-β signaling leading to altered melanoma growth and metastasis.
Wang HX; Sharma C; Knoblich K; Granter SR; Hemler ME
Cell Res; 2015 Mar; 25(3):370-85. PubMed ID: 25656846
[TBL] [Abstract][Full Text] [Related]
6. SB-431542, a small molecule transforming growth factor-beta-receptor antagonist, inhibits human glioma cell line proliferation and motility.
Hjelmeland MD; Hjelmeland AB; Sathornsumetee S; Reese ED; Herbstreith MH; Laping NJ; Friedman HS; Bigner DD; Wang XF; Rich JN
Mol Cancer Ther; 2004 Jun; 3(6):737-45. PubMed ID: 15210860
[TBL] [Abstract][Full Text] [Related]
7. LRG1 modulates epithelial-mesenchymal transition and angiogenesis in colorectal cancer via HIF-1α activation.
Zhang J; Zhu L; Fang J; Ge Z; Li X
J Exp Clin Cancer Res; 2016 Feb; 35():29. PubMed ID: 26856989
[TBL] [Abstract][Full Text] [Related]
8. Microglia-derived TGF-beta as an important regulator of glioblastoma invasion--an inhibition of TGF-beta-dependent effects by shRNA against human TGF-beta type II receptor.
Wesolowska A; Kwiatkowska A; Slomnicki L; Dembinski M; Master A; Sliwa M; Franciszkiewicz K; Chouaib S; Kaminska B
Oncogene; 2008 Feb; 27(7):918-30. PubMed ID: 17684491
[TBL] [Abstract][Full Text] [Related]
9. Transforming Growth Factor-β Is an Upstream Regulator of Mammalian Target of Rapamycin Complex 2-Dependent Bladder Cancer Cell Migration and Invasion.
Gupta S; Hau AM; Al-Ahmadie HA; Harwalkar J; Shoskes AC; Elson P; Beach JR; Hussey GS; Schiemann WP; Egelhoff TT; Howe PH; Hansel DE
Am J Pathol; 2016 May; 186(5):1351-60. PubMed ID: 26988652
[TBL] [Abstract][Full Text] [Related]
10. MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-β signalling pathway.
Lynch J; Fay J; Meehan M; Bryan K; Watters KM; Murphy DM; Stallings RL
Carcinogenesis; 2012 May; 33(5):976-85. PubMed ID: 22382496
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of transforming growth factor-β signaling potentiates tumor cell invasion into collagen matrix induced by fibroblast-derived hepatocyte growth factor.
Oyanagi J; Kojima N; Sato H; Higashi S; Kikuchi K; Sakai K; Matsumoto K; Miyazaki K
Exp Cell Res; 2014 Aug; 326(2):267-79. PubMed ID: 24780821
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of Smad2 inhibits proliferation of gingival epithelial cells.
Shimoe M; Yamamoto T; Shiomi N; Tomikawa K; Hongo S; Yamashiro K; Yamaguchi T; Maeda H; Takashiba S
J Periodontal Res; 2014 Jun; 49(3):290-8. PubMed ID: 23738652
[TBL] [Abstract][Full Text] [Related]
13. Effects of transforming growth factor-β inhibitor on the proliferation of glioma stem/progenitor cell.
Zhang Q; Guo W; Di C; Lou M; Li H; Zhao Y
Pol J Pathol; 2017; 68(4):312-317. PubMed ID: 29517201
[TBL] [Abstract][Full Text] [Related]
14. Positive and negative regulation of podoplanin expression by TGF-β and histone deacetylase inhibitors in oral and pharyngeal squamous cell carcinoma cell lines.
Ohta M; Abe A; Ohno F; Hasegawa Y; Tanaka H; Maseki S; Kondo E; Kurita K; Nakanishi H
Oral Oncol; 2013 Jan; 49(1):20-6. PubMed ID: 22840788
[TBL] [Abstract][Full Text] [Related]
15. The role of leucine-rich alpha-2-glycoprotein-1 in proliferation, migration, and invasion of tumors.
Lin M; Liu J; Zhang F; Qi G; Tao S; Fan W; Chen M; Ding K; Zhou F
J Cancer Res Clin Oncol; 2022 Feb; 148(2):283-291. PubMed ID: 35037101
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting TGF-beta signaling restores immune surveillance in the SMA-560 glioma model.
Tran TT; Uhl M; Ma JY; Janssen L; Sriram V; Aulwurm S; Kerr I; Lam A; Webb HK; Kapoun AM; Kizer DE; McEnroe G; Hart B; Axon J; Murphy A; Chakravarty S; Dugar S; Protter AA; Higgins LS; Wick W; Weller M; Wong DH
Neuro Oncol; 2007 Jul; 9(3):259-70. PubMed ID: 17522330
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of TGF-β Signaling in Gliomas by the Flavonoid Diosmetin Isolated from
Yan Y; Liu X; Gao J; Wu Y; Li Y
Molecules; 2020 Jan; 25(1):. PubMed ID: 31906574
[No Abstract] [Full Text] [Related]
18. An imbalance between Smad and MAPK pathways is responsible for TGF-beta tumor promoting effects in high-grade gliomas.
Nickl-Jockschat T; Arslan F; Doerfelt A; Bogdahn U; Bosserhoff A; Hau P
Int J Oncol; 2007 Feb; 30(2):499-507. PubMed ID: 17203233
[TBL] [Abstract][Full Text] [Related]
19. Analysis of transforming growth factor β signaling in chronic rhinosinusitis.
Li YC; An YS; Wang T; Zang HR
Chin Med J (Engl); 2013; 126(17):3340-3. PubMed ID: 24033961
[TBL] [Abstract][Full Text] [Related]
20. SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells.
Matsuyama S; Iwadate M; Kondo M; Saitoh M; Hanyu A; Shimizu K; Aburatani H; Mishima HK; Imamura T; Miyazono K; Miyazawa K
Cancer Res; 2003 Nov; 63(22):7791-8. PubMed ID: 14633705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
